Dacepton 5 mg/ml, Infusionslösung

7680671250015 CH-67125 Infusionslösung
Dacepton 5 mg/ml, Infusionslösung
Dacepton 5 mg/ml, Infusionslösung
Dacepton 5 mg/ml, Infusionslösung
1 / 3
google

Article details

Package size
5 x 20 ml
Selling units
5
Measure
Durchstechflasche(n)
Galenic form
Infusionslösung
Galenic group
Injektion/Infusion

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
17/01/2022
Patient information leaflet
Français
17/01/2022
Patient information leaflet
Italien
17/01/2022
Summary of Product Characteristics
Allemand
17/01/2022
Summary of Product Characteristics
Français
17/01/2022

Detailed composition

Substance Quantity Type Category
(N/A)
5.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
1.0 MG Substance ANTOX
(N/A)
- Substance HNIDK

Reimbursement information

Public price
CHF 205.40
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/03/2023

Authorization holder

Medius AG

4132 Muttenz

Authorization information

Swissmedic authorization number
67125
Drug name
Dacepton 5 mg/ml, Infusionslösung
Galenic form
LSPA
ATC Code
N04BC07
Authorization status
Z
Dispensing category
B
First authorization
10/12/2018
Authorization expiration date
31/12/9999
IT Number
01.08.0.
Domain
Human medicine
Field of application
Morbus Parkinson

Package details

Description (FR)
DACEPTON sol perf 100 mg/20ml 5 flac 20 ml
Description (DE)
DACEPTON Inf Lös 100 mg/20ml 5 Durchstf 20 ml
Market launch
10/12/2018
Narcotic (BTM)
No